NSUN2 and neoplasm: Knocking out NSUN2 rendered tumors more sensitive to cisplatin, reducing tumor growth and increasing DNA damage levels, which was associated with reduced MRE11 recruitment to damage sites, impairing homologous recombination repair [40].